Potential antigenic mismatch of the H3N2 component of the 2019 Southern Hemisphere influenza vaccine.

Link to article at PubMed

Related Articles

Potential antigenic mismatch of the H3N2 component of the 2019 Southern Hemisphere influenza vaccine.

Clin Infect Dis. 2019 Aug 11;:

Authors: Gouma S, Weirick M, Hensley SE

Abstract
Here, we find that the egg-adapted H3N2 component of the 2019 Southern Hemisphere influenza vaccine elicits an antibody response in ferrets that is highly focused on antigenic site A of hemagglutinin. This is potentially problematic since most H3N2 viruses currently circulating in the Southern Hemisphere possess antigenic site A substitutions.

PMID: 31400756 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *